Healthcare >> CEO Interviews >> October 26, 2004
DR. AVTAR DHILLON joined Genetronics Biomedical Corporation as President
and Chief Executive Officer in September 2001 and a Director in October
2001. Prior to joining the company, Dr. Dhillon was engaged by MDS
Capital Corporation as a consultant in July 1998 and subsequently became
investment manager in August 1999 and Vice President in 2000. MDS
Capital Corporation is one of North America's leading healthcare venture
capital organizations. In July 1989, Dr. Dhillon started a medical
clinic and subsequently practiced family medicine for over 12 years.
From March 1997 to July 1998, Dr. Dhillon acted as consultant to
Cardiome Pharma Corporation, a biotechnology company listed on the
Toronto Stock Exchange. Dr. Dhillon has also acted as consultant to IGT
Pharmaceuticals from May 1997 to November 1997, consultant to Inflazyme
Pharmaceuticals Inc. from March 1996 to March 1997, and biotechnology
investment analyst to various institutions from November 1996 to July
1998. Dr. Dhillon is a member of the following: B.C. Biotechnology
Alliance, College of Physicians and Surgeons, B.C. Medical Association,
Canadian Medical Association and College of Family Practitioners. Dr.
Dhillon has a Bachelor of Science honors degree in Physiology and an MD
degree from the University of British Columbia. Profile
on at the company over the last couple of quarters that investors should
focus on?
Dr. Dhillon: We've developed a lot
